Medical Journals

Bcl11b Participates in the Activation of Il2 Gene Expression in Cd4+ T Lymphocytes.

Authors:
  • Cismasiu Valeriu B
  • Ghanta Sailaja
  • Duque Javier
  • Albu Diana I
  • Chen Hong-Mei
  • Kasturi Rohini
  • Avram Dorina

From: Center for Cell Biology and Cancer Research (MC-165), Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.

Blood

  • Publish Date: Oct 2006
  • ISSN: 0006-4971
  • Volume: 108
  • Issue: 8
  • Pages: 2695-702
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cismasiu Valeriu B, Ghanta Sailaja, Duque Javier, et al. Bcl11b Participates in the Activation of Il2 Gene Expression in Cd4+ T Lymphocytes.. Blood Oct 2006;108:2695-702

Abstract

BCL11A and BCL11B are transcriptional regulators important for lymphopoiesis and previously associated with hematopoietic malignancies. Ablation of the mouse Bcl11b locus results in failure to generate double-positive thymocytes, implicating a critical role of Bcl11b in T-cell development. However, BCL11B is also expressed in CD4+ T lymphocytes, both in resting and activated states. Here we show both in transformed and primary CD4+ T cells that BCL11B participates in the control of the interleukin-2 (IL2) gene expression following activation through T-cell receptor (TCR). BCL11B augments expression from the IL2 promoter through direct binding to the US1 site. In addition, BCL11B associates with the p300 coactivator in CD4+ T cells activated through TCR, which may account for its transcriptional activation function. These results provide the first evidence that BCL11B, originally described as a transcriptional repressor, activates transcription of a target gene in the context of T-cell activation.

Mesh Headings (Keywords): Animals, Base Sequence, Binding Sites, CD4-Positive T-Lymphocytes, Cells, Cultured, DNA, DNA-Binding Proteins, Gene Expression Regulation, Humans, Interleukin-2, Jurkat Cells, Lymphocyte Activation, Mice, Molecular Sequence Data, Promoter Regions (Genetics), RNA, Small Interfering, Receptors, Antigen, T-Cell, Recombinant Proteins, Repressor Proteins, Transduction, Genetic, Tumor Suppressor Proteins, p300-CBP Transcription Factors


Check for Full Text / PubMed Unique Identifier (PMID): 16809611


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.